Tyche Industries Limited

BSE:532384 Stock Report

Market Cap: ₹1.7b

Tyche Industries Past Earnings Performance

Past criteria checks 0/6

Tyche Industries's earnings have been declining at an average annual rate of -8%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 0.2% per year. Tyche Industries's return on equity is 9.8%, and it has net margins of 18%.

Key information

-8.0%

Earnings growth rate

-8.1%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate0.2%
Return on equity9.8%
Net Margin18.0%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Tyche Industries makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532384 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247271311100
30 Jun 24680123980
31 Mar 246971221000
31 Dec 238081421030
30 Sep 23786145990
30 Jun 23773137950
31 Mar 23756142960
31 Dec 22671116920
30 Sep 2261689850
30 Jun 22660108880
31 Mar 2263093850
31 Dec 2163289890
30 Sep 21725137990
30 Jun 21725159890
31 Mar 21794200930
31 Dec 20776223790
30 Sep 20763207730
30 Jun 20763205730
31 Mar 20743176750
31 Dec 19705150790
30 Sep 19630118790
30 Jun 1958283720
31 Mar 1953971720
31 Dec 1851765770
30 Sep 1849859750
30 Jun 1847552780
31 Mar 1851659750
31 Dec 1754257970
30 Sep 1753154980
30 Jun 1751247940
31 Mar 1743931680
31 Dec 16461261030
30 Sep 16482181010
30 Jun 1646412620
31 Mar 16552251020
31 Dec 15563451050
30 Sep 15557451050
30 Jun 1563937640
31 Mar 1563919970
31 Dec 1458121080
30 Sep 1469481060
30 Jun 1486131510
31 Mar 141,043551020

Quality Earnings: 532384 has a high level of non-cash earnings.

Growing Profit Margin: 532384's current net profit margins (18%) are lower than last year (18.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532384's earnings have declined by 8% per year over the past 5 years.

Accelerating Growth: 532384's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 532384 had negative earnings growth (-9.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).

Return on Equity

High ROE: 532384's Return on Equity (9.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 22:44
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tyche Industries Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijay MadunalaFirstCall Research
Shailaja CH.FirstCall Research